GlaxoSmithKline Continues Down A Dangerous Path

Print Email

Two more studies show that GlaxoSmithKline (GSK) blockbuster diabetes drug Avandia has significant health risks.

According to The Wall Street Journal "the Food and Drug Administration is considering whether Avandia’s use should be restricted." Studies show that the drug can increase risk of heart attack. In a research paper form Wake Forest University doctors  found that patients taking Avandia had a 42% greater chance of having a heart attack than those in the control group.

The whole incident begs that question of what major drug companies never take their own products off the market when there is overwhelming evidence that they create health risk. There must be some actuary who works out the balance between profit and potential liability if court cases for wrongful death begin to emerge.

Of course, that leaves out the question of ethics.

Douglas A. McIntyre